Human non-autologous platelet derived Extracellular Vesicle therapy(Exopharm)

人非自体血小板衍生细胞外囊泡疗法(Exopharm)

Report date: 2025/02/28 10:17:48

Base Information

Drug NameHuman non-autologous platelet derived Extracellular Vesicle therapy(Exopharm)
Drug Alias NamePlexaris
ClassificationBiologics > Exosomes
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesExopharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesExopharm Ltd
Inactive CompaniesN/A
Active IndicationsWounds and Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A